Johnson & Johnson completes divestiture of LifeSca
Post# of 11802
Oct. 2, 2018 6:43 AM ET|About: Johnson & Johnson (JNJ)|By: Mamta Mayani, SA News Editor
Johnson & Johnson (NYSE:JNJ) has completed the divestiture of its LifeScan business to Platinum Equity for ~$2.1B.
JNJ will discuss this transaction during its scheduled quarterly earnings call on October 16.
Shares are down a fraction premarket.
Not much news here. But it is interesting. Probably more news coming out later today on this.